JNP Medi-LSK Global PS Signs Usage Contract for Clinical Document Management Solution 'Maven Docs'

Jung Kwonho, CEO of JNP Medi (left), and Lee Youngjak, CEO of LSK Global PS, signed a contract for the use of Maven Docs, the nation's first clinical trial document creation and management solution, on the 26th of last month.

[Asia Economy Reporter Kim Young-won] J&P Medi announced on the 2nd that it signed a contract last month on the 26th with its global clinical partner LSK Global Pharma Services (LSK Global PS) to use 'Maven Docs,' the first clinical trial document creation and management solution in Korea.

Maven Docs is a solution launched after about a year of development following an MOU signed by the two companies in October last year. This solution was developed to address inefficiencies caused by frequent revisions despite the strict review and approval processes involved in clinical trial document creation.

Maven Docs standardizes the creation of various clinical trial documents such as clinical trial protocols, case report forms, clinical trial manuals, and consent forms, and supports simplified document management through data linkage. The document creation feature, Composer, enables easy document creation based on form standardization and data linkage. The Viewer function allows setting permissions for document viewing and downloading. Additionally, it complies with the U.S. Food and Drug Administration (FDA) regulations on electronic records and electronic signatures, '21 CFR part 11,' providing optimized electronic signature functionality for clinical trials without the need to purchase separate software.

Lee Young-jak, CEO of LSK Global PS, said, "Various documents required during the clinical trial process go through complex procedures, and if inconsistencies or errors occur between related documents during this process, time and costs increase, potentially disrupting the clinical trial plan. We expect that using Maven Docs will enable more efficient document creation and management, providing faster and more stable clinical trial services."

Jung Kwon-ho, CEO of J&P Medi, stated, "Maven Docs is a representative service that aligns with our company's value of streamlining the entire clinical trial process through digital transformation. We will lead a paradigm shift in the clinical trial industry through the advancement of the Maven platform and various services in the future."

This content was produced with the assistance of AI translation services.